FACT Capital’s Medtronic MDT Stock Holding History

FACT Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,738	Closed	-$1.46M	–	14
2022 Q4	$1.46M	Buy	+18,738	New	+$1.52M	0.85%	12

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

FACT Capital's MDT Position: Q1 2023 in Review

FACT Capital sold out of Medtronic (MDT) in Q1 2023, closing a stake of 18,738 shares — an estimated $1.46M sold.

FACT Capital first reported a position in MDT in Q4 2022 and held it in 1 quarter. The position peaked at $1.46M in Q4 2022. 1,992 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

FACT Capital reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
FACT Capital sold 18,738 Medtronic shares in Q1 2023, an estimated $1.46M.
FACT Capital first reported a position in Medtronic in Q4 2022 and held it in 1 quarter.
FACT Capital's Medtronic position peaked at $1.46M in Q4 2022.
1,992 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on FACT Capital's 13F filing for Q1 2023, filed 15 May 2023.